|
Biomarkers of Benzene Exposure in Inner City Residents Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Biomarkers of Benzene Exposure in Inner City Residents conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Biomarkers of Benzene Exposure in Inner City Residents Clinical research trials and Biomarkers of Benzene Exposure in Inner City Residents healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Biomarkers of Benzene Exposure in Inner City Residents. Biomarkers of Benzene Exposure in Inner City Residents Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Biomarkers of Benzene Exposure in Inner City Residents clinical trial. Participants typically obtain the most effective healthcare available for their Biomarkers of Benzene Exposure in Inner City Residents condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Biomarkers of Benzene Exposure in Inner City Residents  Biomarkers of Benzene Exposure in Inner City Residents
Biomarkers of Benzene Exposure in Inner City Residents
For Condition: Lung Disease,Cancer
Status: Recruiting
Sponsor(s): National Institute of Environmental Health Sciences (NIEHS) , Mickey Leland National Urban Air Toxics Research Center,Environmental Protection Agency (EPA)
Synopsis: This study compares air pollution exposures of residents in a South Baltimore community next to major industry with those in a comparison community with much less industry nearby. Parents and children as well as adults alone will be included. Air levels of 3 chemicals that have been found in increased amounts in the community as well as two urinary breakdown products of benzene will be measured. Participants will limit the amount of sorbate preserved foods they eat as this preservative interferes with one of the benzene breakdown products. Benzene air and urine exposure measurements will be compared in each community as well as between communities. By including children and parents we will gather exposure information on children who may be more sensitive that adults to these types of pollution. Lastly, by restricting the amount of food preserved with sorbates, we can decide if this improves the use of ttMA for people exposed to benzene from air pollution.
Details: The current study focuses on an environmental exposure assessment of a South Baltimore community residing near a heavily industrialized area. Exposure differences between this community and a reference community that is demographically similar to South Baltimore but has limited industrial impact will be assessed. Participants will include both parent child study pairs and adults. Outdoor, indoor and personal 72 hour badge monitoring for benzene, 1,3-butadiene and carbon tetrachloride will be performed. Two urinary biomarkers for benzene exposure, trans,trans-muconic acid (ttMA) and s-phenylmercapturic acid (S-PMA) will be measured at 3 daily time points over the 3 day period. Past work indicates that ingestion of sorbate preserved foods causes substantial interference with the benzene biomarker, ttMA. Therefore, participants will restrict their intake of sorbate preserved foods during the study. On the day of greatest dietary restriction, a 24 hour benzene personal air measurement will be obtained. Data analysis will include correlations of benzene badge exposure measurements and urinary biomarkers. Air and biomarker benzene exposure data will be compared between communities. Linear regression modeling will be used to determine important explanatory factors of the biomarkers. The inclusion of parent child study pairs will also allow correlation of benzene air levels and urinary biomarkers between parents and children. This will provide exposure information on a potentially susceptible subpopulation, e.g. children, and allow assessment of potential for age-related differences in benzene metabolism. Finally, we will be able to determine if dietary restriction is practical and results in greater specificity of ttMA as a benzene biomarker.
Eligibility:
Study Type: Observational, Screening, Cross-Sectional, Random Sample
Minimum Age/Maximum Age: 3 Years/
Genders: Both
Protocol Entry Criteria: residence in one of the study communities
Total Enrollment: 90
Location and Contact Information:
Johns Hopkins University School of Hygiene and Public Health *Recruiting*
Baltimore, Maryland, 21205
United States
Recruiting Virginia Weaver 410-955-4130
Additional Information:
Study ID Numbers: 7780-CP-001;
Study Start Date:
Record last reviewed: April 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00014963
Other Cancer Studies:
1. Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
2. Trastuzumab Plus R115777 in Treating Patients with Advanced or Metastatic Cancer
3. (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy
4. Evaluation for NCI Surgery Branch Clinical Studies
5. A Phase 1 Trial of ALIMTA (pemetrexed) in Patients With Locally Advanced or Metastatic Cancer
Related Studies:
Other Cancer Clinical Trials
Other Maryland Clinical Trials
Other Baltimore Clinical Trials
Biomarkers of Benzene Exposure in Inner City Residents
|
|
|
|
|
|
|
|
